CD2AP and Cognitive impairment: A study of 73 non-demented and demented patients revealed that CD2AP polymorphism rs9349407 was associated with a 6% lower Mini-Mental State Examination score, a questionnaire used to measure cognitive impairment and screen for dementia [144].